← FDA Drug Approvals (Drugs@FDA)

OPZELURA

NDA · New Drug Application · Sponsor: INCYTE CORP · Approved 2021-09-21

Drug application

FDA Application #

NDA215309

Application type

New Drug Application

Brand name

OPZELURA

Generic name

RUXOLITINIB

Active ingredients

RUXOLITINIB PHOSPHATE

Dosage form

CREAM

Route

TOPICAL

Marketing status

Prescription

Sponsor

INCYTE CORP

Manufacturer

Incyte Corporation

First approval

2021-09-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown